Search Clinical Trials
598,375 trials
ID
Status
Phase
Title
Sponsor
NCT07766122
Analysis of the Performance of PSMA Emission Tomography in Patients With Prostate Cancer Treated With HIFUUniversity Hospital, ToulouseNot Yet RecruitingPhase 4
NCT07766122Not Yet Recruiting
Phase 4
Analysis of the Performance of PSMA Emission Tomography in Patients With Prostat...University Hospital, Toul...
NCT07766317
Autologous Tumor Infiltrating Lymphocyte (TIL) GT201 Infusion.Gritbio Medicine, Inc.Not Yet RecruitingPhase 1
NCT07766317Not Yet Recruiting
Phase 1
Autologous Tumor Infiltrating Lymphocyte (TIL) GT201 Infusion.Gritbio Medicine, Inc.
NCT07766720
Effects of Eggshell Membrane and Curcumin Extract Supplementation, Separately or Combined, on Recovery From Intense ExerciseESM Technologies, LLCRecruitingNot Applicable
NCT07766720Recruiting
Not Applicable
Effects of Eggshell Membrane and Curcumin Extract Supplementation, Separately or...ESM Technologies, LLC
NCT07765043
Electromagnetic Therapy for Cervicogenic DysphagiaUmm Al-Qura UniversityCompletedNot Applicable
NCT07765043Completed
Not Applicable
Electromagnetic Therapy for Cervicogenic DysphagiaUmm Al-Qura University
NCT07765524
A Phase I/II Open-label, Single-arm, Multicenter Clinical Study to Evaluate the Safety and Efficacy of FKC289 in Subjects With Relapsed/Refractory Primary AL AmyloidosisShenzhen Fosun Kairos Biotechnology Co., Ltd.Not Yet RecruitingPhase 1
NCT07765524Not Yet Recruiting
Phase 1
A Phase I/II Open-label, Single-arm, Multicenter Clinical Study to Evaluate the...Shenzhen Fosun Kairos Bio...
NCT07766655
A Study to Evaluate the Efficacy and Safety of AXS-05 for Smoking Cessation in AdultsAxsome Therapeutics, Inc.RecruitingPhase 3
NCT07766655Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of AXS-05 for Smoking Cessation in A...Axsome Therapeutics, Inc.
NCT07765966
Phase 1 Dose Escalation Study of RXIM002 in Autoimmune CytopeniasRiboX Therapeutics Ltd.Not Yet RecruitingPhase 1
NCT07765966Not Yet Recruiting
Phase 1
Phase 1 Dose Escalation Study of RXIM002 in Autoimmune CytopeniasRiboX Therapeutics Ltd.
NCT07764809
Driving Time and Facial Skin Hydration Asymmetry in Florida DriversIAS Skin CareNot Yet Recruiting
NCT07764809Not Yet Recruiting
—
Driving Time and Facial Skin Hydration Asymmetry in Florida DriversIAS Skin Care
NCT07766382
Artificial Intelligence-Assisted Ultrasound Assessment of Laryngeal Mask Airway PlacementDuzce UniversityRecruiting
NCT07766382Recruiting
—
Artificial Intelligence-Assisted Ultrasound Assessment of Laryngeal Mask Airway...Duzce University
NCT07764939
Comparative Effects of CIMT and TOT on Hand Function in Post Stroke PatientsRiphah International UniversityActive Not RecruitingNot Applicable
NCT07764939Active Not Recruiting
Not Applicable
Comparative Effects of CIMT and TOT on Hand Function in Post Stroke PatientsRiphah International Univ...
NCT07766759
A Phase 1 Study of FXR0906 in Healthy Adults With or Without Elevated TriglyceridesFosun Pharmaceutical Industrial Development (Shenzhen) Co., Ltd.Not Yet RecruitingPhase 1
NCT07766759Not Yet Recruiting
Phase 1
A Phase 1 Study of FXR0906 in Healthy Adults With or Without Elevated Triglyceri...Fosun Pharmaceutical Indu...
NCT07764536
Augmenting Parent Management Training for Child Temper Outbursts Using a Digital ToolNational Institute of Mental Health (NIMH)Not Yet Recruiting
NCT07764536Not Yet Recruiting
—
Augmenting Parent Management Training for Child Temper Outbursts Using a Digital...National Institute of Men...
NCT07766187
Combination Therapy Using Durvalumab and Histotripsy for Treatment of Intrahepatic CholangiocarcinomaHistoSonics, Inc.Not Yet RecruitingPhase 2
NCT07766187Not Yet Recruiting
Phase 2
Combination Therapy Using Durvalumab and Histotripsy for Treatment of Intrahepat...HistoSonics, Inc.
NCT07766512
Five-year Follow-up After Sars-CoV-2 Infection: Prevalence and Evolution of Post-acute Sequalae of COVID-19 (PASC)Fondazione Policlinico Universitario Agostino Gemelli IRCCSNot Yet Recruiting
NCT07766512Not Yet Recruiting
—
Five-year Follow-up After Sars-CoV-2 Infection: Prevalence and Evolution of Post...Fondazione Policlinico Un...
NCT07766356
Study of Cognitive-Linguistic Profiles: The Role of Executive Control in AphasiaUniversity Hospital, ToulouseNot Yet RecruitingNot Applicable
NCT07766356Not Yet Recruiting
Not Applicable
Study of Cognitive-Linguistic Profiles: The Role of Executive Control in AphasiaUniversity Hospital, Toul...
NCT07765147
Evaluating iCare COMPASS as a Visual Field Diagnostic ToolIndiana UniversityCompletedNot Applicable
NCT07765147Completed
Not Applicable
Evaluating iCare COMPASS as a Visual Field Diagnostic ToolIndiana University
NCT07764718
Temporal Interference Brain Stimulation for Adults With Drug-Resistant Epilepsy Undergoing Stereo-EEG MonitoringDuke UniversityNot Yet RecruitingNot Applicable
NCT07764718Not Yet Recruiting
Not Applicable
Temporal Interference Brain Stimulation for Adults With Drug-Resistant Epilepsy...Duke University
NCT07765394
A Clinical Trial to Evaluate the Effects of A Supplement on Supporting Signs of Metabolic HealthCitruslabsCompletedNot Applicable
NCT07765394Completed
Not Applicable
A Clinical Trial to Evaluate the Effects of A Supplement on Supporting Signs of...Citruslabs
NCT07765576
Ex Vivo Thermal Damage Assessment During Electrocautery Cutting of Explanted Biopolymer-Infiltrated TissueResearch IncNot Yet Recruiting
NCT07765576Not Yet Recruiting
—
Ex Vivo Thermal Damage Assessment During Electrocautery Cutting of Explanted Bio...Research Inc
NCT07764679
A Clinical Study Evaluating the Diagnostic Performance and Safety of PET for the Deposition of Aβ Plaques in the Brain of Participants With Normal Cognitive Function, MCI and AD Using [18F]Fluorbetazine InjectionHTA Co., Ltd.RecruitingPhase 3
NCT07764679Recruiting
Phase 3
A Clinical Study Evaluating the Diagnostic Performance and Safety of PET for the...HTA Co., Ltd.
Result Breakdown
Not yet recruiting12 (60%)
Recruiting4 (20%)
Completed3 (15%)
Active, not recruiting1 (5%)
not_applicable7 (35%)
Not Specified5 (25%)
Phase 14 (20%)
Phase 32 (10%)
Phase 41 (5%)
Phase 21 (5%)